Comments on: "Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program" by JY Jenny, Y Bulaid, P Boisrenoult, N Bonin, P Henky, et al. published in Orthop Traumatol Surg Res 2020;106:1533-1538

Orthop Traumatol Surg Res. 2021 May;107(3):102878. doi: 10.1016/j.otsr.2021.102878. Epub 2021 Mar 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthroplasty, Replacement, Knee* / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Hemorrhage
  • Humans
  • Thromboembolism* / etiology
  • Thromboembolism* / prevention & control

Substances

  • Fibrinolytic Agents